Signaling in myocardial hypertrophy: Life after calcineurin?

Circulation Research

Volumn 84, Issue 6, 1999, Pages 633-646

  Sugden, Peter H ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Calcineurin; Calcium movement; Mitogen activated protein kinase cascade; Myocardial hypertrophy and failure; Transcription

Indexed keywords

CALCINEURIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C;

ENZYME ACTIVITY; HEART FAILURE; HEART MUSCLE CELL; HEART OUTPUT; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE WALL; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033515536     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.84.6.633     Document Type: Review

References (202)

1. Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, Fauad-Tarazi F, Horan MJ, Marcus M, Massie B, Pfeffer MA, Re RN, Roccella EJ, Savage D, Shub C. The heart in hypertension. N Engl J Med. 1992;327:998-1008.
2. Eichhorn E, Bristow MR. Medical therapy can improve the biological properties of the chronically failing heart: a new era in the treatment of heart failure. Circulation. 1996;94:2285-2296.
3. Wagoner LE, Walsh RA. The cellular pathophysiology of progression to heart failure. Curr Opin Cardiol. 1996;11:237-244.
4. 2+ currents in compensated hypertrophy and heart failure. Cardiovasc Res. 1998;37: 300-311.
5. Wickenden AD, Kaprielian R, Kassiri Z, Tsoporis JN, Tsushima R, Fishman GI, Backx PH. The role of action potential elongation and altered intracellular calcium handling in the pathogenesis of heart failure. Cardiovasc Res. 1998;37:312-323.
6. Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated cells in the adult mammalian heart. Circ Res. 1998;83:1-14.
7. Soonpaa MH, Field LJ. Survey of studies examining cardiomyocyte DNA synthesis. Circ Res. 1998;83:15-26.
8. Krämer BK, Nishida M, Kelly RA, Smith TW. Endothelins: myocardial actions of a new class of cytokines. Circulation. 1992;85:350-356.
9. Sugden PH, Bogoyevitch MA. Endothelin-1-dependent signaling pathways in the myocardium. Trends Cardiovasc Med. 1996;6:87-94.
10. Sei CA, Glembotski CC. Calcium dependence of phenylephrine-, endothelin-, and potassium chloride-stimulated atrial natriuretic factor secretion from long term primary neonatal rat atrial cardiocytes. J Biol Chem. 1990;265:7166-7172.
11. Sadoshima J, Izumo S. Signal transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro. Circ Res. 1993;73:424-438.
12. 2+-dependent signaling. Circ Res. 1995;76:1-15.
13. Olson EN, Molkentin JD. Prevention of cardiac hypertrophy by calcineurin inhibition: hope or hype? Circ Res. 1999;84:623-632.
14. Molkentin JD, Lu J-R, Antos C, Markham B, Richardson J, Robbins J, Grant SR, Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 1998;93:215-228.
15. Barinaga M. Signaling pathways may lead to better heart-failure therapies. Science. 1998;280:383.
16. Izumo S, Aoki H. Calcineurin: the missing link in cardiac hypertrophy. Nat Med. 1998;4:661-662.
17. Chien KR, Knowlton KU, Zhu H, Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J. 1991;5: 3037-3046.
18. Komuro I, Yazaki Y. Control of cardiac gene expression by mechanical stress. Annu Rev Physiol. 1993;55:55-75.
19. Sugden PH, Clerk A. Cellular mechanisms of cardiac hypertrophy. J Mol Med. 1998;76:725-746.
20. 1-adrenergic agonists as a primary response gene in cultured rat cardiac myocytes. J Biol Chem. 1994;269:26227-26233.
21. Hasenfuss G. Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res. 1998;37:279-289.
22. Mably JD, Liew CC. Factors involved in cardiogenesis and the regulation of cardiac-specific gene expression. Circ Res. 1996;79:4-13.
23. Wiesner RJ, Ehmke H, Faulhaber J, Zak R, Rüegg JC. Dissociation of left ventricular hypertrophy, β-myosin heavy chain gene expression, and myosin isoform switch in rats, after ascending aortic stenosis. Circulation. 1997;95:1253-1259.
24. Chien KR. Cardiac muscle diseases in genetically engineered mice: evolution of molecular physiology. Am J Physiol. 1995;269: H755-H766.
25. Becker KD, Gottshall KR, Chien KR. Strategies for studying cardiovascular phenotypes in genetically manipulated mice. Hypertension. 1996; 27:495-501.
26. MacLellan WR, Schneider MD. Success in failure: modeling cardiac decompensation in transgenic mice. Circulation. 1998;97:1433-1435.
27. Ng WA, Grupp IL, Subramaniam A, Robbins J. Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ Res. 1991;68:1742-1750.
28. 2+ ATPase gene in hearts of transgenic mice accelerates calcium transients and cardiac relaxation. J Clin Invest. 1997;100:380-389.
29. 2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin. J Clin Invest. 1998;101:1385-1393.
30. Gottshall KR, Hunter JJ, Tanaka N, Dalton N, Becker KD, Ross J Jr, Chien KR. Ras-dependent pathways induce obstructive hypertrophy in echo-selected transgenic mice. Proc Natl Acad Sci U S A. 1997;94: 4710-4715.
31. Sugden PH, Clerk A. Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signal. 1997;9: 337-351.
32. Sugden PH, Clerk A. "Stress-responsive" mitogen-activated protein kinases in the myocardium. Circ Res. 1998;83:345-352.
33. Sheng Z, Knowlton K, Chen J, Hoshijama M, Brown JH, Chien KR. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway: divergence from downstream CT-1 signals for myocardial cell hypertrophy. J Biol Chem. 1997;272:5783-5791.
34. Kodama H, Fukuda K, Pan J, Makino S, Sano M, Takahashi T, Hori S, Ogawa S. Biphasic activation of the JAK/STAT pathway by angiotensin II in rat cardiomyocytes. Circ Res. 1998;82:244-250.
35. McWhinney CD, Dostal D, Baker K. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes. J Mol Cell Cardiol. 1998;30: 751-761.
36. 2+/calmodulin-dependent protein kinase II regulates atrial natriuretic factor gene expression in ventricular myocytes. J Biol Chem. 1997;272:31203-31208.
37. Aoki H, Sadoshima J, Izumo S. The critical role of myosin light chain phosphorylation in cardiac myofibrillogenesis in cardiac hypertrophy in vitro. Circulation. 1998;98(suppl I):I-839. Abstract.
38. Alvarez E, Northwood IC, Gonzalez FA, Latour DA, Seth A, Abate C, Curran T, Davis RJ. Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation. J Biol Chem. 1991;266: 15277-15285.
39. Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem. 1993;268:14553-14556.
40. Madhani HD, Fink GR. The riddle of MAP kinase signaling specificity. Trends Genet. 1998;14:151-155.
41. Vojtek AB, Der CJ. Increasing complexity of the Ras signaling pathway. J Biol Chem. 1998;273:19925-19928.
42. Mackay DJG, Hall A. Rho GTPases. J Biol Chem 1998;273: 20685-20688.
43. Clerk A, Bogoyevitch MA, Andersson MB, Sugden PH. Differential activation of protein kinase C isoforms by endothelin-1 and phenylephrine, and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts. J Biol Chem. 1994;269:32848-32857.
44. Pucéat M, Hilal-Dandan R, Strulovici B, Brunton LL, Brown JH. Differential regulation of protein kinase C isoforms in isolated neonatal and adult rat cardiomyocytes. J Biol Chem. 1994;269:16938-16944.
45. Rybin VO, Steinberg SF. Protein kinase C isoform expression and regulation in the developing heart. Circ Res. 1994;74:299-309.
46. Clerk A, Bogoyevitch MA, Fuller SJ, Lazou A, Parker PJ, Sugden PH. Expression of protein kinase C isoforms during cardiac ventricular development. Am J Physiol. 1995;269:H1087-H1097.
47. 1 adrenergic and phorbol ester stimulation. J Mol Cell Cardiol. 1988;20:1081-1085.
48. Dunnmon PM, Iwaki K, Henderson SA, Sen A, Chien KR. Phorbol esters induce immediate-early genes and activate cardiac gene transcription in neonatal rat myocardial cells. J Mol Cell Cardiol. 1990;22: 901-910.
49. Bogoyevitch MA, Marshall CJ, Sugden PH. Hypertrophic agonists stimulate the activities of the protein kinases c-Raf and A-Raf in cultured ventricular myocytes. J Biol Chem. 1995;270:26303-26310.
50. Bogoyevitch MA, Glennon PE, Andersson MB, Clerk A, Lazou A, Marshall CJ, Parker PJ, Sugden PH. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes: the potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy. J Biol Chem. 1994;269:1110-1119.
51. Bogoyevitch MA, Glennon PE, Sugden PH. Endothelin-1, phorbol esters and phenylephrine stimulate MAP kinase activities in ventricular cardiomyocytes. FEBS Lett. 1993;317:271-275.
52. Marais R, Light Y, Paterson HF, Marshall CJ. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J. 1995;14:3136-3145.
53. Marais R, Light Y, Paterson HF, Mason CS, Marshall CJ. Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic Ras and tyrosine kinases. J Biol Chem. 1997;272:4378-4383.
54. Cohen P. The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol. 1997;7:353-361.
55. Bogoyevitch MA, Ketterman AJ, Sugden PH. Cellular stresses differentially activate the c-Jun N-terminal protein kinases and the extracellular signal-regulated protein kinases in cultured ventricular myocytes. J Biol Chem. 1995;270:29710-29717.
56. Clerk A, Michael A, Sugden PH. Stimulation of multiple mitogen-activated protein kinase sub-families by oxidative stress and phosphorylation of the small heat shock protein, HSP25/27, in neonatal ventricular myocytes. Biochem J. 1998;333:581-589.
57. Clerk A, Michael A, Sugden PH. The G protein coupled receptor agonists, endothelin-1 and phenylephrine, stimulate p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes. J Cell Biol. 1998;142:523-535.
58. Johnson NL, Gardner AM, Diener KM, Lange-Carter CA, Gleavy J, Jarpe MB, Minden A, Karin M, Zon LI, Johnson GL. Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death. J Biol Chem. 1996;271: 3229-3237.
59. Zechner D, Craig R, Hanford DS, McDonough PM, Sabbadini RA, Glembotski CC. MKK6 activates myocardial cell NF-κB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner. J Biol Chem. 1998;273:8232-8239.
60. Wang Y, Huang S, Sah VP, Ross J, Brown JH, Han J, Chien KR. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem. 1998;273:2161-2168.
61. Nemoto S, Sheng Z, Lin A. Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy. Mol Cell Biol. 1998;18:3518-3526.
62. 2α stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes. J Biol Chem. 1996;271:1179-1186.
63. 2α induces cardiac myocyte hypertrophy in vitro and cardiac growth in vivo. Am J Physiol. 1996;271:H2197-H2208.
64. 2α in cultured neonatal rat ventricular myocytes. Circ Res. 1998;83:167-178.
65. Glennon PE, Kaddoura S, Sale EM, Sale GJ, Fuller SJ, Sugden PH. Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach down-regulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. Circ Res. 1996;78: 954-961.
66. Thorburn J, Carlson M, Mansour SJ, Chien KR, Ahn NG, Thorburn A. Inhibition of a signaling pathway in cardiac muscle cells by active mitogen-activated protein kinase kinase. Mol Biol Cell. 1995;6: 1479-1490.
67. Fuller SJ, Davies EL, Gillespie-Brown J, Sun H, Tonks NK. Mitogen-activated protein kinase phosphatase 1 inhibits the stimulation of gene expression by hypertrophic agonists in cardiac myocytes. Biochem J. 1997;323:313-319.
68. Post GR, Goldstein D, Thuerauf DJ, Glembotski CC, Brown JH. Dissociation of p42 and p44 mitogen-activated protein kinase activation from receptor-induced hypertrophy in neonatal rat ventricular myocytes. J Biol Chem. 1996;271:8452-8457.
69. Hines WA, Thorburn A. Ras and Rho are required for Gαq-induced hypertrophic gene expression in neonatal rat cardiac myocytes. J Mol Cell Cardiol. 1998;30:485-494.
70. Zechner D, Thuerauf DJ, Hanford DS, McDonough PM, Glembotski CC. A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression. J Cell Biol. 1997;139:115-127.
71. Clerk A, Sugden PH. Phosphorylation of c-Jun and ATF2 in ventricular myocytes by endothelin and phenylephrine. Biochem Soc Trans. 1997; 25:222S.
72. Thuerauf DJ, Arnold ND, Zechner D, Hanford DS, DeMartin KM, McDonough PM, Prywes R, Glembotski CC. p38-mitogen-activated protein kinase mediates the transcriptional induction of the atrial natriuretic factor gene through a serum response element: a potential role for the transcription factor ATF6. J Biol Chem. 1998;273:20636-20643.
73. Clerk A, Gillespie-Brown J, Fuller SJ, Sugden PH. Stimulation of phosphatidylinositol hydrolysis, protein kinase C translocation, and mitogen-activated protein kinase activation by bradykinin in rat ventricular myocytes: dissociation from the hypertrophic response. Biochem J. 1996;317:109-118.
74. 1-adrenergic stimulation. J Biol Chem. 1994;269:13490-13496.
75. Kariya K, Karns LR, Simpson PC. Expression of a constitutively activated mutant of the β-isozyme of protein kinase C in cardiac myocytes stimulates the promoter of the β-myosin heavy chain isogene. J Biol Chem. 1991;266:10023-10026.
76. Shubeita HE, Martinson EA, van Bilsen M, Chien KR, Brown JH. Transcriptional activation of the cardiac myosin light chain 2 and atrial natriuretic factor genes by protein kinase C in neonatal rat ventricular myocytes. Proc Natl Acad Sci U S A. 1992;89:1305-1309.
77. Decock JB, Gillespie-Brown J, Parker PJ, Sugden PH, Fuller SJ. Classical, novel and atypical isoforms of PKC stimulate ANF-and TRE/AP-1-regulated-promoter activity in ventricular cardiomyocytes. FEBS Lett. 1994;356:275-278.
78. Thorburn A, Thorburn J, Chen S-Y, Powers S, Shubeita HE, Feramisco JR, Chien KR. HRas-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy. J Biol Chem. 1993;268:2244-2249.
79. Fuller SJ, Gillespie-Brown J, Sugden PH. Oncogenic raf, src, and ras stimulate a hypertrophic pattern of gene expression and increase cell size in neonatal rat ventricular myocytes. J Biol Chem. 1998;273: 18146-18152.
80. Kovačič B, Ilić D, Damsky CH, Gardner DG. c-Src plays a role in endothelin-dependent hypertrophy of the cardiac myocyte. J Biol Chem. 1998;273:35185-35193.
81. q interface to inhibit in vivo pressure overload hypertrophy. Science. 1998;280:574-577.
82. Hunter JJ, Tanaka N, Rockman HA, Ross J Jr, Chien KR. Ventricular expression of a MLC-2-v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. J Biol Chem. 1995;270:23173-23178.
83. Bowman JC, Steinberg SF, Jiang T, Geenan DL, Fishman GI, Buttrick PM. Expression of protein kinase C β in the heart causes hypertrophy in adult mice and sudden death in neonates. J Clin Invest. 1997;100: 2189-2195.
84. D'Angelo DD, Sakata Y, Lorenz JN, Boivin GP, Walsh RA, Liggett SB, Dorn GW, II. Transgenic Gαq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci U S A. 1997;94:8121-8126.
85. Wakasaki H, Koya D, Schoen FJ, Jirousek MR, Ways DK, Hoit BD, Walsh RA, King GL. Targeted overexpression of protein kinase C β2 isoform in myocardium causes cardiomyopathy. Proc Natl Acad Sci U S A. 1997;94:9320-9325.
86. Sakata Y, Hoit BD, Liggett SB, Walsh RA, Dorn GW II. Decompensation of pressure-overload hypertrophy in Gαq-overexpressing mice. Circulation. 1998;97:1488-1495.
87. Amano M, Fukata Y, Kaibuchi K. Regulation of cytoskeleton and cell adhesions by the small GTPase Rho and its targets. Trends Cardiovasc Med. 1998;8:162-168.
88. Mellor H, Parker PJ. The extended PKC superfamily. Biochem J. 1998; 332:281-292.
89. 1-adrenergic receptor signaling in cardiomyocytes: dissociation of Ras and Rho pathways. J Biol Chem. 1996;271:31185-31190.
90. Thorburn J, Xu S, Thorburn A. MAP kinase and Rho-dependent signals interact to regulate gene expression but not actin morphology in cardiac muscle cells. EMBO J. 1997;16:1888-1900.
91. Aoki H, Izumo S, Sadoshima J. Angiotensin II activates RhoA in cardiac myocytes: a critical role of RhoA in angiotensin II-induced premyofibril formation. Circ Res. 1998;82:666-676.
92. Hoshijima M, Sah VP, Wang Y, Chien KR, Brown JH. The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes: involvement of Rho kinase. J Biol Chem. 1998;273:7725-7730.
93. Guerini D. Calcineurin: not just a simple protein phosphatase. Biochem Biophys Res Commun. 1997;235:271-275.
94. Klee CB, Ren H, Wang X. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem. 1998;273:13367-13370.
95. O'Keefe SJ, Tamura J, Kincaid RL, Tocci MJ, O'Neill EA. FK-506-and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature. 1992;357:692-694.
96. Rao A. NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunol Today. 1994;15:274-281.
97. Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol. 1997;15:707-747.
98. Shibasaki F, Price ER, Milan D, McKeon F. Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4. Nature. 1996;382:370-373.
99. q-coupled receptors in lymphoid and non-lymphoid cells. J Biol Chem. 1996;271:10429-10432.
100. Boss V, Abbott KL, Wang X-F, Pavlath GK, Murphy TJ. The cyclosporin A-sensitive nuclear factor of activated T cells (NFAT) proteins are expressed in vascular smooth muscle cells: differential localization of NFAT isoforms and induction of NFAT-mediated transcription by phospholipase C-coupled cell surface receptors. J Biol Chem. 1998;273: 19664-19671.
101. Chow C-W, Rincón M, Cavanagh J, Dickens M, Davis RJ. Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway. Science. 1997;278:1638-1641.
102. Zhu J, Shibasaki F, Price R, Guillemot JC, Yano T, Dotsch V, Wagner G, Ferrara P, McKeon F. Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKK1. Cell. 1998;93: 851-861.
103. Beals CR, Sheridan CR, Turck CW, Gardner P, Crabtree GR. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science. 1997;275:1930-1933.
104. Klemm JD, Beals CR, Crabtree GR. Rapid targeting of nuclear protein to the cytoplasm. Curr Biol. 1997;7:638-644.
105. Matsuda S, Moriguchi T, Koyasu S, Nishida E. T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin. J Biol Chem. 1998;273:12378-12382.
106. Arceci RJ, King AA, Simon MC, Orkin SH, Wilson DB. Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart. Mol Cell Biol. 1993;13:2235-2246.
107. Molkentin JD, Olson EN. GATA4: a novel transcriptional regulator of cardiac hypertrophy? Circulation. 1997;96:3833-3835.
108. Grépin C, Dagnino L, Robitaille L, Haberstroh L, Antakly T, Nemer M. A hormone-encoding gene identifies a pathway for cardiac but not skeletal muscle gene transcription. Mol Cell Biol. 1994;14:3115-3129.
109. Hasegawa K, Lee SJ, Jobe SM, Markham BE, Kitsis RN. cis-acting sequences that mediate induction of β-myosin heavy chain expression during left ventricular hypertrophy due to aortic constriction. Circulation. 1997;96:3943-3953.
110. Lee Y, Shioi T, Kasahar H, Jobe SM, Wiese RJ, Markham BE, Izumo S. The cardiac tissue-restricted homeobox protein Csx/Nkx2.5 physically associates with the zinc finger protein GATA4 and cooperatively activates atrial natriuretic factor gene expression. Mol Cell Biol. 1998; 18:3120-3129.
111. Komuro I, Izumo S. Csx: a murine homeobox-containing gene specifically expressed in the developing heart. Proc Natl Acad Sci U S A. 1993;90:8145-8149.
112. Lints TJ, Parsons LM, Hartley L, Lyons I, Harvey RP. Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. Development. 1993;119:419-431.
113. 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes: evidence for involvement of p70 S6 kinase. Circ Res. 1997;81:176-186.
114. i, and contraction in ventricular myocytes. Am J Physiol. 1993;265: H793-H800.
115. 2+ and pH in isolated beating rabbit hearts and in myocytes loaded with the indicator indo-1. J Physiol (Cambr). 1994;480:203-215.
116. + exchanger is impaired in cardiac hypertrophy. J Clin Invest. 1997;99:123-135.
117. 1-adrenoceptors: an overview. Pharmacol Rev. 1993;45:147-175.
118. Pucéat M, Vassort G. Neurohumoral modulation of intracellular pH in the heart. Cardiovasc Res. 1995;29:178-183.
119. + exchangers of mammalian cells. J Biol Chem. 1997;272:22373-22376.
120. Kretsinger RH. Calcium-binding proteins. Annu Rev Biochem. 1976;45: 239-266.
121. Kretsinger RH. Structure and evolution of calcium-modulated proteins. CRC Crit Rev Biochem. 1980;8:119-174.
122. 2+ ions can affect intracellular pH in mammalian cardiac muscle. Nature. 1983;301: 522-524.
123. Sugden PH, Fuller SJ. Correlations between cardiac protein synthesis rates, intracellular pH and the concentrations of creatine metabolites. Biochem J. 1991;273:339-346.
124. 2+ response amplitude and duration. Nature. 1997;386:855-858.
125. Dolmetsch RE, Xu K, Lewis RS. Calcium oscillations increase the efficiency and specificity of gene transcription. Nature. 1998;392: 933-936.
126. Gruver CL, DeMayo F, Goldstein MA, Means AR. Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice. Endocrinology. 1993;133:376-388.
127. de la Pompa JL, Timmerman LA, Takimoto H, Yoshida H, Elia AJ, Samper E, Potter J, Wakeham A, Marengere L, Langille BL, Crabtree GR, Mak TW. Role of the NF-ATc transcription factor in the morphogenesis of cardiac valves and septum. Nature. 1998;392:182-186.
128. Henning SW, Cantrell DA. GTPases in antigen receptor signalling. Curr Opin Immunol. 1998;10:322-329.
129. Chen L, Glover JNM, Hogan PG, Rao S, Harrison SC. Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA. Nature. 1998;392:42-48.
130. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem. 1995;270:16483-16486.
131. Minden A, Karin M. Regulation and function of the JNK subgroup of MAP kinases. Biochim Biophys Acta. 1997;1333:F85-F104.
132. Reif K, Cantrell DA. Networking Rho family GTPase in lymphocytes. Immunity. 1998;8:395-401.
133. Livingstone C, Patel G, Jones N. ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J. 1995;14: 1785-1797.
134. Van Dam H, Wilhelm D, Herr I, Steffen A, Herrlich P, Angel P. ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J. 1995;14: 1798-1811.
135. Whitmarsh AJ, Shore P, Sharrocks AD, Davis RJ. Integration of MAP kinase signal transduction pathways at the serum response element. Science. 1995;269:403-407.
136. Bogoyevitch MA, Andersson MB, Gillespie-Brown J, Clerk A, Glennon PE, Fuller SJ, Sugden PH. Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. Biochem J. 1996;314:115-121.
137. McDonough PM, Hanford DS, Sprenkle AB, Mellon NR, Glembotski CC. Collaborative roles for c-Jun N-terminal kinase, c-Jun, serum response factor, and Sp1 in calcium-regulated myocardial gene expression. J Biol Chem. 1997;272:24046-24053.
138. Ho PD, Zechner DK, He H, Dillmann WH, Glembotski CC, McDonough PM. The Raf-MEK-ERK cascade represents a common pathway for the alteration of intracellular calcium by Ras and protein kinase C in cardiac myocytes. J Biol Chem. 1998;273:21730-21735.
139. Sussman MA, Lim HW, Gude N, Taigen T, Olson EN, Robbins J, Colbert MC, Gualberto A, Wieczorek DF, Molkentin JD. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science. 1998; 281:1690-1693.
140. Luo X, Shyu K-G, Gualberto A, Walsh K. Calcineurin inhibitors and cardiac hypertrophy. Nat Med. 1998;4:1092-1093.
141. Müller JG, Nemoto S, Laser M, Carabello BA, Menick DR. Calcineurin inhibition and cardiac hypertrophy. Science. 1998;282:1007. Available at: http://www.sciencemag.org/cgi/content/full/282/5391/1007a. Accessed November 13, 1998.
142. Molkentin JD. Calcineurin inhibition and cardiac hypertrophy: response. Science. 1998;282:1007. Available at: http://www.sciencemag.org/cgi/ content/full/282/5391/1007a. Accessed November 13, 1998.
143. +-ATPase activity in renal tubule cells. Proc Natl Acad Sci U S A. 1992;89:7394-7397.
144. Radermacher J, Meiners M, Bramlage C, Kliem V, Behrend M, Schlitt HJ, Pichlmayr R, Koch KM, Brunkhorst R. Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin versus FK-506. Transpl Int. 1998;11:3-10.
145. Rowan RA, Billingham ME. Pathologic changes in the long-term transplanted heart: a morphometric study of myocardial hypertrophy, vascularity, and fibrosis. Hum Pathol. 1990;21:767-772.
146. Lipkin GW, Tucker B, Giles M, Raine AE. Ambulatory blood pressure and left ventricular mass in cyclosporin-and non-cyclosporin-treated renal transplant patients. J Hypertens. 1993;11:439-442.
147. Ventura HO, Lavie CJ, Messerli FH, Smart FW, Stapleton DD, Ochsner JL. Cardiovascular adaptation to cyclosporine-induced hypertension. J Hum Hypertens. 1994;8:233-237.
148. Globits S, De Marco T, Schwitter J, Sakuma H, O'Sullivan M, Rifkin C, Keith F, Chatterjee K, Parmley WW, Higgins CB. Assessment of early left ventricular remodeling in orthotopic heart transplant recipients with cine magnetic resonance imaging: potential mechanisms. J Heart Lung Transplant. 1997;16:504-510.
149. Chin ER, Olson EN, Richardson JA, Yang Q, Humphries C, Shelton JM, Wu H, Zhu W, Bassel-Duby R, Williams RS. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev. 1998;12:2499-2509.
150. Sabbah HN, Hansen-Smith F, Sharov VG, Kono T, Lesch M, Gengo PJ, Steffen RP, Levine TB, Goldstein S. Decreased proportion of type I myofibers in skeletal muscle of dogs with chronic heart failure. Circulation. 1993;87:1729-1737.
151. Harrington D, Coats AJS. Skeletal muscle abnormalities and evidence for their role in symptom generation in chronic heart failure. Eur Heart J. 1997;18:1865-1872.
152. Stern MD. Theory of excitation-contraction coupling in cardiac muscle. Biophys J. 1992;63:497-517.
153. Gwathmey JK, Morgan JP. Altered calcium handling in pressure-overload hypertrophy in the ferret. Circ Res. 1985;57:836-843.
154. Gwathmey JK, Copelas L, McKinnin R, Schoen FJ, Feldman MD, Grossman W, Morgan JP. Altered intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res. 1987; 61:70-76.
155. Santella L, Carafoli E. Calcium signaling in the cell nucleus. FASEB J. 1997;11:1091-1109.
156. Sato Y, Ferguson DG, Sako H, Dorn GW, II, Kadambi VJ, Yatani A, Hoit BD, Walsh RA, Kranias EG. Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice. J Biol Chem. 1998;273: 28470-28477.
157. Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, Doetschman T, Kranias EG. Targeted ablation of the phospholamban gene is associated with markedly enhanced cardiac contractility and loss of β agonist stimulation. Circ Res. 1994;75:401-409.
158. 2+ levels in the heart by sorcin and FKBP12, two accessory proteins of ryanodine receptors. Trends Pharmacol Sci. 1998;19:479-482.
159. Shou W, Aghdasi B, Armstrong DL, Guo Q, Bao S, Charng MJ, Mathews LM, Schneider MD, Hamilton SL, Matzuk MM. Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12. Nature. 1998;391:489-492.
160. Perez PJ, Ramos-Franco J, Fill M, Mignery GA. Identification and functional reconstitution of the type 2 inositol 1,4,5-trisphosphate receptor from ventricular cardiac myocytes. J Biol Chem. 1997;272: 23961-23969.
161. Cameron AM, Nucifora NC Jr, Fung ET, Livingston DJ, Aldape RA, Ross CA, Snyder SH. FKBP12 binds the inositol 1,4,5-trisphosphate receptor at leucine-proline (1400-1401) and anchors calcineurin to this FK-506-like domain. J Biol Chem. 1997;272:27582-27588.
162. Halestrap AP, Connern CP, Griffiths EJ, Kerr PM. Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury. Mol Cell Biochem. 1997;174:167-172.
163. Bernardi P. The permeability transition pore: control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death. Biochim Biophys Acta. 1998;1275:5-9.
164. Halestrap AP, Kerr PM, Javadov S, Woodfield KY. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. Biochim Biophvs Acta. 1998;1366: 79-94.
165. Halestrap AP, Woodfield KY, Connern CP. Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to adenine nucleotide translocase. J Biol Chem. 1997;272:3346-3354.
166. Griffiths EJ, Halestrap AP. Protection by cyclosporin A of ischemia/ reperfusion-induced damage in isolated rat hearts. J Mol Cell Cardiol. 1993;25:1461-1469.
167. Massoudy P, Zahler S, Kupatt C, Reder E, Becker BF, Gerlach E. Cardioprotection by cyclosporine A in experimental ischemia and reperfusion: evidence for a nitric oxide-dependent mechanism mediated by endothelin. J Mol Cell Cardiol. 1997;29:535-544.
168. Weinbrenner C, Liu GS, Downey JM, Cohen MV. Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia. Cardiovasc Res. 1998;38:676-684.
169. MacLellan WR, Schneider MD. Death by design. Circ Res. 1997;81: 137-144.
170. Haunstetter A, Izumo S. Apoptosis, basic mechanisms and implications for cardiovascular disease. Circ Res. 1998;82:1111-1129.
171. 2+-activated cell death in mammalian cells. J Cell Biol. 1995;131:735-743.
172. Shibasaki F, Kondo E, Akagi T, McKeon F. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature. 1997;386:728-731.
173. Genestier L, Dearden-Badet MT, Bonnefoy-Berard N, Lizard G, Revillard JP. Cyclosporin A and FK-506 inhibit activation-induced cell death in the murine WEHI-231 B cell line. Cell Immunol. 1994;155: 283-291.
174. Reed JC. Double identity for proteins of the Bcl-2 family. Nature. 1997;387:773-776.
175. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw BA. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 1996;335:1182-1189.
176. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P. Apoptosis in the failing human heart. N Engl J Med. 1997;336: 1131-1141.
177. Walter DH, Haendele J, Galle J, Zeiher AM, Dimmeler S. Cyclosporin A inhibits apoptosis of human endothelial cells by preventing release of cytochrome c from mitochondria. Circulation. 1998;98:1153-1157.
178. Massagué J. TGF-β signal transduction. Annu Rev Biochem. 1998;67: 753-791.
179. Dell'Acqua ML, Scott JD. Protein kinase A anchoring. J Biol Chem. 1997;272:12881-12884.
180. Shubeita HE, McDonough PM, Harris AN, Knowlton KU, Glembotski CC. Brown JH, Chien KR. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes: a paracrine mechanism for myocardial cell hypertrophy. J Biol Chem. 1990;265:20555-20562.
181. Ito H, Hirata Y, Hiroe M, Tsujino M, Adachi S, Takamoto T, Nitta M, Taniguchi K, Marumo F. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res. 1991;69:209-215.
182. 1 receptor subtype. Circ Res. 1993;73: 413-423.
183. 1-adrenergic receptor interaction: evidence for independent regulation of growth and beating. Circ Res. 1985;56:884-894.
184. Knowlton KU, Baracchini E, Ross RS, Harris AN, Henderson SA, Evans SM, Glembotski CC, Chien KR. Co-regulation of the atrial natriuretic factor and cardiac myosin light chain-2 genes during α-adrenergic stimulation of neonatal rat ventricular cells: identification of cis sequences within an embryonic and a constitutive contractile protein gene which mediate inducible expression. J Biol Chem. 1991; 266:7759-7768.
185. Parker TG, Packer SE, Schneider MD. Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes. J Clin Invest. 1990;85:507-514.
186. Ito H, Hiroe M, Hirata Y, Tsujino M, Adachi S, Shichiri M, Koike A, Nogami A, Marumo F. Insulin-like growth factor-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured rat cardiomyocytes. Circulation. 1993;87:1715-1721.
187. Pennica D, King KL, Shaw KJ, Luis E, Rullamas J, Luoh S-M, Darbonne WC, Knutzon DS, Yen R, Chien KR, Baker JB, Wood WI. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Nad Acad Sci U S A. 1995;92:1142-1146.
188. Komuro I, Kaida T, Shibazaki Y, Kurabayashi M, Katoh Y, Hoh E, Takaku F, Yazaki Y. Stretching cardiac myocytes stimulates protooncogene expression. J Biol Chem. 1990;265:3595-3598.
189. Komuro I, Katoh Y, Kaida T, Shibazaki Y, Kurabayashi M, Hoh E, Takaku F, Yazaki Y. Mechanical loading stimulates cell hypertrophy and specific gene expression in cultured rat cardiac myocytes: possible role of protein kinase C activation. J Biol Chem. 1991;266:1265-1268.
190. Sadoshima J, Jahn L, Takahashi T, Kulik TJ, Izumo S. Molecular characterization of stretch-induced adaptation of cultured cardiac cells: an in vitro model of load induced cardiac hypertrophy. J Biol Chem. 1992;267:10551-10560.
191. Sadoshima J, Izumo S. Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J. 1993;12:1681-1692.
192. Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Hiroi Y, Mizuno T, Maemura K, Kurihara H, Aikawa R, Takano H, Yazaki Y. Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J Biol Chem. 1996;271:3221-3228.
193. Liang F, Gardner DG. Autocrine/paracrine determinants of strain-activated brain natriuretic peptide gene expression in cultured cardiac myocytes. J Biol Chem. 1998;273:14612-14619.
194. Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993;75:977-984.
195. Clark WA, Decker ML, Behnke-Barclay M, Janes DM, Decker RS. Cell contact as an independent factor modulating cardiac myocyte hypertrophy and survival in long-term primary culture. J Mol Cell Cardiol. 1998;30:139-155.
196. Thorburn J, Frost JA, Thorburn A. Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle hypertrophy. J Cell Biol. 1994;126: 1565-1572.
197. Thorburn J, McMahon M, Thorburn A. Raf-1 kinase activity is necessary and sufficient for gene expression changes but not sufficient for cellular morphology changes associated with cardiac myocyte hypertrophy. J Biol Chem. 1994;269:30580-30586.
198. Gillespie-Brown J, Fuller SJ, Bogoyevitch MA, Cowley S, Sugden PH. The mitogen-activated protein kinase kinase MEK1 stimulates a pattern of gene expression typical of the hypertrophic phenotype in rat ventricular cardiomyocytes. J Biol Chem. 1995;270:28092-28096.
199. 1-adrenergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy. J Biol Chem. 1997;272:14057-14061.
200. Choukroun G, Hajjar R, Kyriakis JM, Bonventre JV, Rosenzweig A, Force T. Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy. J Clin Invest. 1998;102: 1311-1320.
201. 2-terminal kinase in ventricular muscle cells. J Biol Chem. 1998;273:5423-5426.
202. q leads to cardiac hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc Natl Acad Sci U S A. 1998;95:13893-13898.